Buy Or Sell Opportunity • May 14
Now 22% overvalued Over the last 90 days, the stock has fallen 5.3% to ₩3,770. The fair value is estimated to be ₩3,087, however this is not to be taken as a sell recommendation but rather should be used as a guide only. Revenue has grown by 9.3% over the last 3 years. Earnings per share has declined by 40%. 공시 • Mar 17
HuM&C Co., Ltd., Annual General Meeting, Mar 31, 2026 HuM&C Co., Ltd., Annual General Meeting, Mar 31, 2026, at 14:00 Tokyo Standard Time. Location: auditorium, 17, changeop-ro, sujeong-gu, gyeonggi-do, seongnam South Korea Valuation Update With 7 Day Price Move • Mar 11
Investor sentiment improves as stock rises 16% After last week's 16% share price gain to ₩4,415, the stock trades at a trailing P/E ratio of 48.1x. Average trailing P/E is 17x in the Personal Products industry in South Korea. Total loss to shareholders of 13% over the past three years. 공시 • Feb 14
HuM&C Co., Ltd. announces Annual dividend, payable on April 22, 2026 HuM&C Co., Ltd. announced Annual dividend of KRW 200.0000 per share payable on April 22, 2026, ex-date on April 02, 2026 and record date on April 03, 2026. New Risk • Dec 16
New minor risk - Share price stability The company's share price has been volatile over the past 3 months. It is more volatile than 75% of South Korean stocks, typically moving 8.2% a week. This is considered a minor risk. Share price volatility indicates the stock is highly sensitive to market conditions or economic conditions rather than being sensitive to its own business performance, which may also be inconsistent. It also increases the risk of potential losses in the short term as the stock tends to have larger drops in price more frequently than other stocks. Currently, the following risks have been identified for the company: Minor Risks Share price has been volatile over the past 3 months (8.2% average weekly change). Profit margins are more than 30% lower than last year (1.7% net profit margin). Market cap is less than US$100m (₩40.4b market cap, or US$27.4m). Valuation Update With 7 Day Price Move • Dec 09
Investor sentiment improves as stock rises 16% After last week's 16% share price gain to ₩4,340, the stock trades at a trailing P/E ratio of 47.3x. Average trailing P/E is 20x in the Personal Products industry in South Korea. Total loss to shareholders of 23% over the past three years. New Risk • Sep 24
New minor risk - Share price stability The company's share price has been volatile over the past 3 months. It is more volatile than 75% of South Korean stocks, typically moving 7.4% a week. This is considered a minor risk. Share price volatility indicates the stock is highly sensitive to market conditions or economic conditions rather than being sensitive to its own business performance, which may also be inconsistent. It also increases the risk of potential losses in the short term as the stock tends to have larger drops in price more frequently than other stocks. Currently, the following risks have been identified for the company: Minor Risks Share price has been volatile over the past 3 months (7.4% average weekly change). Profit margins are more than 30% lower than last year (2.6% net profit margin). Market cap is less than US$100m (₩46.8b market cap, or US$33.5m). Buy Or Sell Opportunity • Aug 25
Now 22% overvalued The stock has been flat over the last 90 days, currently trading at ₩4,700. The fair value is estimated to be ₩3,857, however this is not to be taken as a sell recommendation but rather should be used as a guide only. Revenue has grown by 17% over the last 3 years. Meanwhile, the company has become profitable. New Risk • Jul 25
New major risk - Market cap size The company's market capitalization is less than US$10m. Market cap: ₩10.4b (US$7.53m) This is considered a major risk. Companies with a small market capitalization are most likely businesses that have not yet released a product to market or are simply a very small company without a wide reach. Either way, risk is elevated with these companies because there is a chance the product may not come to fruition or the company's addressable market or demand may not be as large as expected. In addition, if the company's size is the main factor, it is less likely to have many investors and analysts following it and scrutinizing its performance and outlook. Currently, the following risks have been identified for the company: Major Risk Market cap is less than US$10m (₩10.4b market cap, or US$7.53m). Minor Risk Profit margins are more than 30% lower than last year (5.1% net profit margin). Buy Or Sell Opportunity • Jul 03
Now 21% overvalued Over the last 90 days, the stock has fallen 5.2% to ₩955. The fair value is estimated to be ₩788, however this is not to be taken as a sell recommendation but rather should be used as a guide only. Revenue has grown by 17% over the last 3 years. Meanwhile, the company has become profitable. Valuation Update With 7 Day Price Move • May 13
Investor sentiment deteriorates as stock falls 15% After last week's 15% share price decline to ₩860, the stock trades at a trailing P/E ratio of 12.4x. Average trailing P/E is 15x in the Personal Products industry in South Korea. Total loss to shareholders of 23% over the past year. Reported Earnings • Mar 21
Full year 2024 earnings released: EPS: ₩69.00 (vs ₩210 in FY 2023) Full year 2024 results: EPS: ₩69.00 (down from ₩210 in FY 2023). Revenue: ₩47.2b (down 2.5% from FY 2023). Net income: ₩3.40b (down 67% from FY 2023). Profit margin: 7.2% (down from 21% in FY 2023). The decrease in margin was primarily driven by higher expenses. 공시 • Mar 13
HuM&C Co., Ltd., Annual General Meeting, Mar 26, 2025 HuM&C Co., Ltd., Annual General Meeting, Mar 26, 2025, at 14:00 Tokyo Standard Time. Location: auditorium, 17, changeop-ro, sujeong-gu, gyeonggi-do, seongnam South Korea Reported Earnings • Nov 15
Third quarter 2024 earnings released Third quarter 2024 results: EPS: ₩21.00. Net income: ₩1.08b (up ₩1.08b from 3Q 2023). Reported Earnings • Aug 17
Second quarter 2024 earnings released: EPS: ₩22.00 (vs ₩54.00 in 2Q 2023) Second quarter 2024 results: EPS: ₩22.00 (down from ₩54.00 in 2Q 2023). Revenue: ₩11.0b (down 13% from 2Q 2023). Net income: ₩1.07b (down 60% from 2Q 2023). Profit margin: 9.7% (down from 21% in 2Q 2023). 공시 • Jul 18
HuM&C Co., Ltd. (KOSDAQ:A263920) agreed to acquire Cosmetic subsidiary materials business of Youil Industry Co., Ltd. from Youil Industry Co., Ltd. for KRW 4.3 billion. HuM&C Co., Ltd. (KOSDAQ:A263920) agreed to acquire Cosmetic subsidiary materials business of Youil Industry Co., Ltd. from Youil Industry Co., Ltd. for KRW 4.3 billion on July 16, 2024. The transaction will be financed through reserved funds. For the period ending December 31, 2023, Cosmetic subsidiary materials business of Youil Industry Co., Ltd. reported sales of KRW 5.54 billion. The expected completion of the transaction is August 1, 2024. Valuation Update With 7 Day Price Move • May 21
Investor sentiment improves as stock rises 15% After last week's 15% share price gain to ₩1,282, the stock trades at a trailing P/E ratio of 7x. Average trailing P/E is 25x in the Personal Products industry in South Korea. Total loss to shareholders of 16% over the past year. Reported Earnings • May 19
First quarter 2024 earnings released First quarter 2024 results: EPS: ₩27.00. Net income: ₩1.28b (up ₩1.28b from 1Q 2023). Reported Earnings • Mar 22
Full year 2023 earnings released: EPS: ₩210 (vs ₩45.76 in FY 2022) Full year 2023 results: EPS: ₩210 (up from ₩45.76 in FY 2022). Revenue: ₩48.4b (up 36% from FY 2022). Net income: ₩10.3b (up 352% from FY 2022). Profit margin: 21% (up from 6.4% in FY 2022). The increase in margin was driven by higher revenue. New Risk • Oct 10
New minor risk - Financial data availability The company's latest financial reports are more than 6 months old. Last reported fiscal period ended December 2022. This is considered a minor risk. If the company has not reported its earnings on time, it may have been delayed due to audit problems or it may be finding it difficult to reconcile its accounts. Currently, the following risks have been identified for the company: Minor Risks Latest financial reports are more than 6 months old (reported December 2022 fiscal period end). Large one-off items impacting financial results. Market cap is less than US$100m (₩59.9b market cap, or US$44.5m). Valuation Update With 7 Day Price Move • Aug 10
Investor sentiment improves as stock rises 24% After last week's 24% share price gain to ₩1,328, the stock trades at a trailing P/E ratio of 28.5x. Average trailing P/E is 27x in the Personal Products industry in South Korea. New Risk • Jun 16
New major risk - Share price stability The company's share price has been volatile over the past 3 months. It is more volatile than 75% of South Korean stocks, typically moving 12% a week. This is considered a minor risk. Share price volatility indicates the stock is highly sensitive to market conditions or economic conditions rather than being sensitive to its own business performance, which may also be inconsistent. It also increases the risk of potential losses in the short term as the stock tends to have larger drops in price more frequently than other stocks. Currently, the following risks have been identified for the company: Minor Risks Share price has been volatile over the past 3 months (12% average weekly change). Large one-off items impacting financial results. Market cap is less than US$100m (₩66.9b market cap, or US$52.5m). Valuation Update With 7 Day Price Move • May 18
Investor sentiment improves as stock rises 23% After last week's 23% share price gain to ₩1,615, the stock trades at a trailing P/E ratio of 34.7x. Average trailing P/E is 35x in the Personal Products industry in South Korea. Total loss to shareholders of 51% over the past three years. Valuation Update With 7 Day Price Move • Apr 27
Investor sentiment improves as stock rises 35% After last week's 35% share price gain to ₩1,547, the stock trades at a trailing P/E ratio of 33.2x. Average trailing P/E is 31x in the Personal Products industry in South Korea. Total loss to shareholders of 48% over the past three years.